Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolus (EOLS) Asset Writedowns and Impairment: 2019-2025

Historic Asset Writedowns and Impairment for Evolus (EOLS) over the last 6 years, with Sep 2025 value amounting to $2.2 million.

  • Evolus' Asset Writedowns and Impairment rose 148.59% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year increase of 172.44%. This contributed to the annual value of $2.4 million for FY2024, which is 70.07% up from last year.
  • Latest data reveals that Evolus reported Asset Writedowns and Impairment of $2.2 million as of Q3 2025, which was up 214.37% from $703,000 recorded in Q2 2025.
  • In the past 5 years, Evolus' Asset Writedowns and Impairment registered a high of $2.2 million during Q3 2025, and its lowest value of -$297,000 during Q2 2021.
  • Its 3-year average for Asset Writedowns and Impairment is $713,909, with a median of $703,000 in 2025.
  • In the last 5 years, Evolus' Asset Writedowns and Impairment crashed by 76.60% in 2021 and then skyrocketed by 818.60% in 2024.
  • Over the past 5 years, Evolus' Asset Writedowns and Impairment (Quarterly) stood at $88,000 in 2021, then spiked by 167.05% to $235,000 in 2022, then slumped by 63.40% to $86,000 in 2023, then surged by 818.60% to $790,000 in 2024, then spiked by 148.59% to $2.2 million in 2025.
  • Its last three reported values are $2.2 million in Q3 2025, $703,000 for Q2 2025, and $1.1 million during Q1 2025.